about
Estimation for paired binomial data with application to radiation therapy.Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study.Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.Gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancerThe effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.Impact of educational differences as measure of socioeconomic status on survival for breast cancer patients.Randomized clinical trial on 7-days-a-week post-operative radiotherapy vs concurrent post-operative radiochemotherapy in locally advanced cancer of the oral cavity/oropharynx: a report on acute normal tissue reactions.Alpha/beta (α/β) ratio for prostate cancer derived from external beam radiotherapy and brachytherapy boostThe erythropoietin-receptor pathway modulates survival of cancer cells.Cell-cycle gene expression analysis using real time PCR in locally advanced squamous-cell head and neck cancer.The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients.Does routine clinical practice reproduce the outcome of large prospective trials? The analysis of institutional database on patients with limited-disease small-cell lung cancer.Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision.Tumor volume and growth kinetics in hypothalamic-chiasmatic pediatric low grade gliomas.Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer.Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy.Quantification of concentration and assessment of EGFR mutation in circulating DNA.Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: Association with tumor progressionBlood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancerRandomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicityTime factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patientsIs it reasonable to select the median value of TPot as a cut-off level in prediction of the radiation treatment outcome?How fast is repopulation of tumor cells during the treatment gap?Radiation dose response for subclinical metastasesComment on the paper: Quantifying the position and steepness of radiation dose-response curvesWhy the utility of a normalized dose-response gradient (gamma-factor) should be redefinedContinuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trialThe tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II studyTime factor in radiotherapy and chemotherapy for limited disease small-cell lung cancerThe prognostic value of hemoglobin concentration in postoperative radiotherapy of 835 patients with laryngeal cancerRandomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancerRandomized clinical trial on continuous 7-days-a-week postoperative radiotherapy for high-risk squamous cell head-and-neck cancer: a report on acute normal tissue reactionsStereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patientsA pilot study of accelerated preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative prophylactic liver irradiation in patients with locally advanced rectal cancerThe SIPA1 -313A>G polymorphism is associated with prognosis in inoperable non-small cell lung cancerHigh baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors
P50
Q30667004-1E9A961A-CD2F-4704-8569-46351879BF46Q33441568-A3A639EA-56C9-4BBF-B954-880182E3F094Q33500426-9480E223-33C8-44F9-A913-5BB8ACBE9159Q34193836-065169EB-6043-4068-90B1-A477F446FA22Q34236406-BF1D088E-A813-49B2-8053-9FC4F88918E3Q34358385-D2F65295-7E96-4175-80CF-5BF89D7A66D7Q35166901-300638DA-7188-41A5-A826-200D3089D9E6Q35198383-9D59A3A8-2CA8-4A08-8C2F-A19F318F32F1Q36942589-E4985B27-C1E5-4BBE-8A93-5921A0C79E6AQ37176459-FE75CD77-635C-4169-B96D-CAEB6AF516D4Q37176535-FBD81ABB-7F62-4416-8055-2FA427D01ACAQ40504960-495010A5-8CC9-4078-BAAF-25CBE6BA338BQ40691143-99B1A069-CB8A-435D-9E0D-1EBC095F00F1Q40939223-DA0CE3FB-2ADD-4ED3-BE8E-58876EE83A48Q41877449-B930AD92-B798-4766-8CE1-85292696AB65Q44710873-F5DBA123-C154-47A6-B8A0-CCC34BF13D26Q46793581-8DEF427B-5B93-4032-B26B-3B218B543E46Q48108481-A3E048CF-6643-4159-A7A6-725F3BB96B60Q48494585-CF152E04-88C0-4C82-9E50-37B072DBF31FQ51914996-5DA6F524-8C32-446C-A934-FCDCD9B1D70FQ53584552-A7036E87-F21E-4AEC-AFBE-00C90756A6D5Q60656312-63B5F293-307E-409E-B37B-708B469BA446Q64061711-F93352E3-7A51-49E9-9565-BD75FA046707Q71712868-0395039C-BEA1-4A73-9BB9-617BA04753E4Q73371659-86C0A4DB-3C42-49DB-A415-38A304F3E8ECQ74201999-E464E716-3CC6-4B6F-8043-EB8D751A9F87Q74619637-BC39AEE2-B51E-4497-8691-BD75570C8D29Q74676203-F9363AF0-3833-47AB-BDCA-F771D69070C9Q74752341-F34F459E-22CE-486D-9274-EE5F2BC78466Q77463940-18C83063-FB20-48D5-9331-43A790FA7DA8Q79163888-C550BB5A-9FAA-4B6C-960A-E7CA4B379EFFQ79741716-A7F5AE41-4BA0-4763-A9DE-05F6F9144F28Q80388075-D21C96B2-DB62-4BD7-849A-B8D37269FA8EQ80837650-23D19307-4F85-4D7B-A033-0401BFC2043DQ80878051-7041B58E-A641-47CA-8252-65D0A6B15980Q81202397-85A63AFB-0513-481F-9C3E-A81A79CF0FD5Q82611796-340601A9-60E9-461B-A41C-2BAE44159212Q83858357-0199C13A-6872-4B73-94E1-E9127701DC2CQ85887753-4DAC01C9-90AE-4113-85CA-C7334D3168D5Q88755930-EF27B74B-6E6F-4468-9847-BBC0E6842FB3
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3895-7938
@en
name
Rafal Suwinski
@ast
Rafal Suwinski
@en
Rafal Suwinski
@es
Rafal Suwinski
@nl
type
label
Rafal Suwinski
@ast
Rafal Suwinski
@en
Rafal Suwinski
@es
Rafal Suwinski
@nl
prefLabel
Rafal Suwinski
@ast
Rafal Suwinski
@en
Rafal Suwinski
@es
Rafal Suwinski
@nl
P106
P1153
6603780252
P31
P496
0000-0002-3895-7938